Showing results (1-10 of 36) with videos related to

Sort By:
Pageof 4
Studies in Health Technology and Informatics|August 28, 2014
Assistive system for people with Apraxia using a Markov decision processEmilie M D Jean-Baptiste, Martin Russell, Pia Rothstein
Neuroimage. Clinical|January 23, 2015
Neural correlates of transitive and intransitive action imitation: an investigation using voxel-based morphometryCarolina Bonivento, Pia Rothstein, Glyn Humphreys, et al.
Sensors (Basel, Switzerland)|October 12, 2017
Creating Affording Situations: Coaching through Animate ObjectsChris Baber, Ahmad Khattab, Martin Russell, et al.
Expert Opinion on Investigational Drugs|May 16, 2007
Emerging therapies for pulmonary arterial hypertensionOmar Ali, John Wharton, John Simon Russell Gibbs, et al.
Plos One|January 17, 2019
BA08: An open-label, single-arm, non-randomised, phase 2 trial of cisplatin, methotrexate and vinblastine (CMV) for pure squamous cell cancer of the urinary tractGareth O Griffiths, Richard A Cowan, Kenneth M Grigor, et al.
Conservation Biology : the Journal of the Society for Conservation Biology|August 23, 2008
A global baseline for spawning aggregations of reef fishesYvonne Sadovy De Mitcheson, Andrew Cornish, Michael Domeier, et al.
Plos One|March 3, 2022
The efficacy of a task model approach to ADL rehabilitation in stroke apraxia and action disorganisation syndrome: A randomised controlled trialJo Howe, Winnie Chua, Emily Sumner, et al.
Health Technology Assessment (Winchester, England)|July 20, 2016
TRAPEZE: a randomised controlled trial of the clinical effectiveness and cost-effectiveness of chemotherapy with zoledronic acid, strontium-89, or both, in men with bony metastatic castration-refractory prostate cancerNicholas James, Sarah Pirrie, Ann Pope, et al.
BJU International|September 24, 2017
Real-world uptake, safety profile and outcomes of docetaxel in newly diagnosed metastatic prostate cancerRobert J Rulach, Stephen McKay, Sam Neilson, et al.
Trials|September 18, 2012
Flexible trial design in practice - stopping arms for lack-of-benefit and adding research arms mid-trial in STAMPEDE: a multi-arm multi-stage randomized controlled trialMatthew R Sydes, Mahesh K B Parmar, Malcolm D Mason, et al.
Pageof 4